BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

206 related articles for article (PubMed ID: 37950200)

  • 21. Extrachromosomal DNA (ecDNA): an origin of tumor heterogeneity, genomic remodeling, and drug resistance.
    Pecorino LT; Verhaak RGW; Henssen A; Mischel PS
    Biochem Soc Trans; 2022 Dec; 50(6):1911-1920. PubMed ID: 36355400
    [TBL] [Abstract][Full Text] [Related]  

  • 22. ATAC-seq with unique molecular identifiers improves quantification and footprinting.
    Zhu T; Liao K; Zhou R; Xia C; Xie W
    Commun Biol; 2020 Nov; 3(1):675. PubMed ID: 33188264
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Extrachromosomal oncogene amplification drives tumour evolution and genetic heterogeneity.
    Turner KM; Deshpande V; Beyter D; Koga T; Rusert J; Lee C; Li B; Arden K; Ren B; Nathanson DA; Kornblum HI; Taylor MD; Kaushal S; Cavenee WK; Wechsler-Reya R; Furnari FB; Vandenberg SR; Rao PN; Wahl GM; Bafna V; Mischel PS
    Nature; 2017 Mar; 543(7643):122-125. PubMed ID: 28178237
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Insight on ecDNA-mediated tumorigenesis and drug resistance.
    Huang Q; Zhang S; Wang G; Han J
    Heliyon; 2024 Mar; 10(6):e27733. PubMed ID: 38545177
    [TBL] [Abstract][Full Text] [Related]  

  • 25. ATAC-seq Optimization for Cancer Epigenetics Research.
    Cooper M; Ray A; Bhattacharya A; Dhasarathy A; Takaku M
    J Vis Exp; 2022 Jun; (184):. PubMed ID: 35848835
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Comparison of differential accessibility analysis strategies for ATAC-seq data.
    Gontarz P; Fu S; Xing X; Liu S; Miao B; Bazylianska V; Sharma A; Madden P; Cates K; Yoo A; Moszczynska A; Wang T; Zhang B
    Sci Rep; 2020 Jun; 10(1):10150. PubMed ID: 32576878
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Oncogenic extrachromosomal DNA functions as mobile enhancers to globally amplify chromosomal transcription.
    Zhu Y; Gujar AD; Wong CH; Tjong H; Ngan CY; Gong L; Chen YA; Kim H; Liu J; Li M; Mil-Homens A; Maurya R; Kuhlberg C; Sun F; Yi E; deCarvalho AC; Ruan Y; Verhaak RGW; Wei CL
    Cancer Cell; 2021 May; 39(5):694-707.e7. PubMed ID: 33836152
    [TBL] [Abstract][Full Text] [Related]  

  • 28. BAMscale: quantification of next-generation sequencing peaks and generation of scaled coverage tracks.
    Pongor LS; Gross JM; Vera Alvarez R; Murai J; Jang SM; Zhang H; Redon C; Fu H; Huang SY; Thakur B; Baris A; Marino-Ramirez L; Landsman D; Aladjem MI; Pommier Y
    Epigenetics Chromatin; 2020 Apr; 13(1):21. PubMed ID: 32321568
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Pioneering insights of extrachromosomal DNA (ecDNA) generation, action and its implications for cancer therapy.
    Li Z; Wang B; Liang H; Han L
    Int J Biol Sci; 2022; 18(10):4006-4025. PubMed ID: 35844796
    [TBL] [Abstract][Full Text] [Related]  

  • 30. The genomic and spatial mobility of extrachromosomal DNA and its implications for cancer therapy.
    van Leen E; Brückner L; Henssen AG
    Nat Genet; 2022 Feb; 54(2):107-114. PubMed ID: 35145302
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The evolutionary dynamics of extrachromosomal DNA in human cancers.
    Lange JT; Rose JC; Chen CY; Pichugin Y; Xie L; Tang J; Hung KL; Yost KE; Shi Q; Erb ML; Rajkumar U; Wu S; Taschner-Mandl S; Bernkopf M; Swanton C; Liu Z; Huang W; Chang HY; Bafna V; Henssen AG; Werner B; Mischel PS
    Nat Genet; 2022 Oct; 54(10):1527-1533. PubMed ID: 36123406
    [TBL] [Abstract][Full Text] [Related]  

  • 32. ATAC-Seq Analysis of Accessible Chromatin: From Experimental Steps to Data Analysis.
    Tatara M; Ikeda T; Namekawa SH; Maezawa S
    Methods Mol Biol; 2023; 2577():65-81. PubMed ID: 36173566
    [TBL] [Abstract][Full Text] [Related]  

  • 33. DeNOPA: decoding nucleosome positions sensitively with sparse ATAC-seq data.
    Xu B; Li X; Gao X; Jia Y; Liu J; Li F; Zhang Z
    Brief Bioinform; 2022 Jan; 23(1):. PubMed ID: 34875002
    [TBL] [Abstract][Full Text] [Related]  

  • 34. MMGAT: a graph attention network framework for ATAC-seq motifs finding.
    Wu X; Hou W; Zhao Z; Huang L; Sheng N; Yang Q; Zhang S; Wang Y
    BMC Bioinformatics; 2024 Apr; 25(1):158. PubMed ID: 38643066
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Methods, bioinformatics tools and databases in ecDNA research: An overview.
    Zhao X; Zhao H; Liu Y; Guo Z
    Comput Biol Med; 2023 Dec; 167():107680. PubMed ID: 37976817
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Simple oligonucleotide-based multiplexing of single-cell chromatin accessibility.
    Wang K; Xiao Z; Yan Y; Ye R; Hu M; Bai S; Sei E; Qiao Y; Chen H; Lim B; Lin SH; Navin NE
    Mol Cell; 2021 Oct; 81(20):4319-4332.e10. PubMed ID: 34686316
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Extrachromosomal DNA: An Emerging Hallmark in Human Cancer.
    Wu S; Bafna V; Chang HY; Mischel PS
    Annu Rev Pathol; 2022 Jan; 17():367-386. PubMed ID: 34752712
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Genome-Wide Analysis of Yeast Metabolic Cycle through Metabolic Network Models Reveals Superiority of Integrated ATAC-seq Data over RNA-seq Data.
    Cesur MF; Çakır T; Pir P
    mSystems; 2022 Jun; 7(3):e0134721. PubMed ID: 35695574
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [ATAC-seq and its applications in complex disease].
    Chen M; Zhang Z; Meng ZY; Zhang XJ
    Yi Chuan; 2020 Apr; 42(4):347-353. PubMed ID: 32312703
    [TBL] [Abstract][Full Text] [Related]  

  • 40. ATAC-pipe: general analysis of genome-wide chromatin accessibility.
    Zuo Z; Jin Y; Zhang W; Lu Y; Li B; Qu K
    Brief Bioinform; 2019 Sep; 20(5):1934-1943. PubMed ID: 29982337
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.